STOCK TITAN

Aurora Cannabis Inc - ACB STOCK NEWS

Welcome to our dedicated news page for Aurora Cannabis (Ticker: ACB), a resource for investors and traders seeking the latest updates and insights on Aurora Cannabis.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aurora Cannabis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aurora Cannabis's position in the market.

Rhea-AI Summary
Aurora Cannabis Inc. has scheduled a conference call to discuss its second quarter fiscal year 2024 results on November 9, 2023. The call will be hosted by the CEO and CFO. Aurora is a pioneer in the global cannabis market, serving both medical and consumer markets. The company's brands include Aurora Drift, San Rafael '71, Daily Special, Tasty's, Whistler, Being, and Greybeard. Aurora's common shares trade on the NASDAQ and TSX under the symbol 'ACB'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.56%
Tags
conferences earnings
-
Rhea-AI Summary
Aurora Cannabis announces settlement of patent litigation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.85%
Tags
none
-
Rhea-AI Summary
Aurora Cannabis Inc. closes bought deal offering, saving almost C$2 million in annual interest payments
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.11%
Tags
none
Rhea-AI Summary
Aurora Cannabis launches new brand TASTY'S promising great product and taste. Includes 50% THC pre-rolls and 1,000mg vapes. Targets pre-roll segment growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
Rhea-AI Summary
Aurora Cannabis Inc. receives approval to transfer listing to Nasdaq Capital Market and agrees to repurchase $9.6 million worth of convertible notes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
buyback
-
Rhea-AI Summary
Aurora Cannabis repurchases $12.3 million of convertible senior notes, reducing debt and annual cash interest costs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
buyback
Rhea-AI Summary
Aurora Cannabis launches Honour, a new cannabis cultivar for veterans, with 5% of net profits supporting veteran organizations. Honour contains 20-26% THC and is available now in 15g dried flower. Proceeds from Strain for Heroes sales will contribute to veteran-focused organizations and clinics in Canada.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.74%
Tags
none
-
Rhea-AI Summary
Aurora Cannabis Inc. announced the expansion of its hemp-derived CBD portfolio into Brazil. In partnership with Herbarium, Aurora will launch its full-spectrum, single-source 3% CBD oil in Brazil. The CBD oil is produced at Aurora's GMP-certified production facility in Uruguay. Aurora aims to leverage its leadership in the market to unlock opportunities in South America.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.27%
Tags
partnership
-
Rhea-AI Summary
Aurora Cannabis announces results of 2023 Annual General Meeting
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.79%
Tags
none
Rhea-AI Summary
Aurora Cannabis Inc. (ACB) Achieves Quarterly Net Revenue of $75.1 Million with Strong YoY Growth Across All Business Units. The company delivered its third sequential quarter of positive adjusted EBITDA, supported by Bevo's record quarterly revenue. Cash used in operating activities reduced by $15.5 million YoY, re-affirming the target of positive free cash flow in calendar year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.38%
Tags
earnings
Aurora Cannabis Inc

NYSE:ACB

ACB Rankings

ACB Stock Data

239.50M
54.39M
0.01%
6.96%
7.01%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Edmonton

About ACB

aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.